| Primary |
| Product Used For Unknown Indication |
40.1% |
| Dementia Alzheimer's Type |
19.8% |
| Dementia |
13.0% |
| Hypertension |
4.3% |
| Parkinson's Disease |
2.8% |
| Depression |
2.2% |
| Constipation |
2.0% |
| Acute Myocardial Infarction |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Anxiety |
1.7% |
| Dementia With Lewy Bodies |
1.5% |
| Alzheimer's Disease |
1.4% |
| Incontinence |
1.2% |
| Amnesia |
1.1% |
| Prophylaxis |
1.1% |
| Induction Of Anaesthesia |
0.9% |
| Memory Impairment |
0.9% |
| Back Pain |
0.8% |
| Cognitive Disorder |
0.8% |
| Frontotemporal Dementia |
0.8% |
|
| Vomiting |
9.6% |
| Fall |
9.0% |
| Pleurothotonus |
6.6% |
| Drug Interaction |
6.0% |
| Sinus Bradycardia |
6.0% |
| Neutropenia |
5.4% |
| Torticollis |
5.4% |
| Delirium |
4.8% |
| Electrocardiogram Qt Prolonged |
4.8% |
| Nightmare |
4.8% |
| Nausea |
4.2% |
| Sexual Dysfunction |
4.2% |
| Torsade De Pointes |
4.2% |
| Electrocardiogram Pr Prolongation |
3.6% |
| Gastrointestinal Haemorrhage |
3.6% |
| Heart Rate Decreased |
3.6% |
| Mania |
3.6% |
| Pancytopenia |
3.6% |
| Unresponsive To Stimuli |
3.6% |
| Insomnia |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
27.4% |
| Dementia Alzheimer's Type |
14.3% |
| Anxiety |
11.0% |
| Depression |
11.0% |
| Parkinson's Disease |
7.4% |
| Dementia |
6.3% |
| Hypertension |
4.0% |
| Constipation |
3.4% |
| Bipolar Disorder |
1.7% |
| Dementia With Lewy Bodies |
1.7% |
| Diabetes Mellitus |
1.7% |
| Gastritis |
1.5% |
| Ill-defined Disorder |
1.5% |
| Acute Myocardial Infarction |
1.3% |
| Aggression |
1.1% |
| Back Pain |
1.1% |
| Insomnia |
1.1% |
| Prophylaxis |
1.1% |
| Disturbance In Social Behaviour |
0.8% |
| Headache |
0.8% |
|
| Encephalopathy |
16.4% |
| Withdrawal Syndrome |
8.2% |
| Insomnia |
6.8% |
| Delirium |
5.5% |
| Electrocardiogram Pr Prolongation |
5.5% |
| Nausea |
5.5% |
| Toxicity To Various Agents |
5.5% |
| Urinary Tract Infection |
5.5% |
| Heart Rate Decreased |
4.1% |
| Incoherent |
4.1% |
| Pneumothorax |
4.1% |
| Poisoning |
4.1% |
| Speech Disorder |
4.1% |
| Syncope |
4.1% |
| Bedridden |
2.7% |
| Lung Neoplasm Malignant |
2.7% |
| Nightmare |
2.7% |
| Parkinson's Disease |
2.7% |
| Serotonin Syndrome |
2.7% |
| Sinus Bradycardia |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.7% |
| Hypertension |
7.7% |
| Dementia Alzheimer's Type |
4.5% |
| Atrial Fibrillation |
4.3% |
| Dementia |
3.8% |
| Multiple Sclerosis |
3.8% |
| Pain |
3.6% |
| Depression |
3.2% |
| Diabetes Mellitus |
3.1% |
| Urinary Tract Infection |
2.3% |
| Cardiac Disorder |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Schizophrenia |
1.9% |
| Anticoagulant Therapy |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Supplementation Therapy |
1.7% |
| Gastric Disorder |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Bipolar Disorder |
1.4% |
| Convulsion |
1.4% |
|
| Unresponsive To Stimuli |
10.2% |
| Pneumonia |
9.2% |
| Renal Failure Acute |
8.2% |
| Urinary Tract Infection |
8.2% |
| Weight Decreased |
8.2% |
| Drug Ineffective |
6.1% |
| Death |
5.1% |
| Fall |
5.1% |
| Hallucination |
5.1% |
| Off Label Use |
4.1% |
| Toxicity To Various Agents |
4.1% |
| Weight Increased |
4.1% |
| Convulsion |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Nervous System Neoplasm |
3.1% |
| Pancreatitis |
3.1% |
| Tremor |
3.1% |
| Withdrawal Syndrome |
3.1% |
| Adverse Drug Reaction |
2.0% |
| Arthropathy |
2.0% |
|
| Interacting |
| Hypertension |
26.8% |
| Dementia Alzheimer's Type |
22.0% |
| Osteoporosis |
19.5% |
| Induction Of Anaesthesia |
9.8% |
| Product Used For Unknown Indication |
9.8% |
| Pruritus |
7.3% |
| Depression |
2.4% |
| Pain |
2.4% |
|
| Drug Interaction |
36.4% |
| Nausea |
27.3% |
| Weight Decreased |
27.3% |
| Salivary Hypersecretion |
9.1% |
|
